Pogačar Has the Tour de France All but Won

Tadej Pogačar is the Tour de France. That is the blunt conclusion of everyone with real money on the line ahead of the 2026 race, and it is a verdict delivered not with enthusiasm but with the flat certainty of a settled question. The Slovenian, who reclaimed the yellow jersey in 2024 after Jonas Vingegaard's two-year reign and then defended it again in 2025 in increasingly dominant fashion, has made the world's most prestigious cycling race look like a problem he alone knows how to solve.

The signal here is nearly unambiguous. At 96%, this is not a market expressing a strong preference — it is a market that has run out of doubt. Vingegaard, the only man in recent memory capable of matching Pogačar in the mountains, sits at 3% and slipped further overnight. The rest of the field — Remco Evenepoel, Isaac del Toro, and the others — register as statistical noise. For a race that won't conclude until August, that kind of compression is remarkable. It implies that the people closest to this sport — directeurs sportifs, sports bettors with palmares databases and wattage models, cycling insiders who track winter training loads and team rosters — see no credible challenger scenario, not just no likely one.

What would have to be true in the world for this pricing to make sense? Pogačar would need to be arriving at the 2026 Tour in the same physical condition that has made him the most complete stage racer of his generation: a climber with a sprinter's punch, a time trialist who can hurt pure climbers, and a tactician whose UAE Team Emirates can control a race from the front. Nothing in the public record contradicts that picture. Vingegaard's odds decline suggests that whatever optimism surrounded a Danish comeback has cooled — whether from team instability at Visma-Lease a Bike, injury whispers, or simply the accumulating weight of evidence that closing the gap to Pogačar requires the Slovenian to crack first.

The compression of the field also reflects a structural reality about modern grand tour racing. Pogačar does not merely win; he wins in a way that demoralizes rivals before the decisive climbs arrive. His 2024 and 2025 campaigns erased the competitive uncertainty that made the Pogačar-Vingegaard rivalry so compelling. When one rider makes the race's hardest moments look like training rides, the market stops pricing in competition and starts pricing in coronation.

For anyone who cares about professional cycling — sponsors, broadcasters, race organizers — this unanimity carries consequences. A Tour without a genuine rival narrative is a harder commercial sell, even if the on-road spectacle remains extraordinary. The race director's challenge will be course design that can manufacture suspense, and some betting money appears to be trickling toward young challengers like del Toro as each-way bets on a future heir rather than a genuine 2026 threat. The two paths the money prices as realistic are a Pogačar victory in dominant fashion, or a Pogačar victory after some mid-race drama — illness, crash, a bad day in the Pyrenees — that briefly tightens the narrative before he reasserts control. A Vingegaard resurgence is the scenario that would break the market's read entirely, and at 3%, it is priced as an outside possibility, not a credible plan.

What would confirm the consensus? Simply, nothing happening. Pogačar arriving at the Grand Départ healthy, his team intact, the route favoring the climbers who fear him most — that is the path the money has already mapped. What would shatter it is a medical withdrawal, a crash, or a Vingegaard who arrives in July looking like 2023. Until then, the story the serious money is telling is not that Pogačar might win the 2026 Tour de France. It is that he already has.